Abstract
Radioembolization represents an effective tool for the treatment of primary and secondary liver tumors. Adequate use of this therapy requires knowledge and a multidisciplinary effort in order to obtain optimal results and avoid therapy-specific complications. A great deal of research has been undertaken in order to understand the angiographic, technical, and safety aspects concerning liver radioembolization. The most common complications of radioembolization include non-target radiation (pancreatitis, GI ulcers, cholecystitis), radiation pneumonitis, radiation-induced liver disease (radiation hepatitis), and biliary complications.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ashizawa K, Matsunaga N, Aso N et al (1991) Bile lake: a complication of transcatheter hepatic arterial infusion and embolization therapy. Nipon Iagaku Hoshasen Gakkai Zasshi 51:121–126
Carretero C, Munoz-Navas M, Betes M et al (2007) Gastroduodenal injury after radioembolization of hepatic tumors. Am J Gastroenterol 102:1–5
Covey AM, Brody LA, Maluccio MA, Getradjdman GJ, Brown KT (2002) Variant hepatic arterial anatomy revisited: digital substraction angiography performed in 600 patients. Radiology 224:542–547
De Luis E, Bilbao JI, Garcia-Jalon de Ciercoles JA et al (2008) In vivo evaluation of a new embolic spherical particle “Hepasphere” in a kidney animal model. Cardiovasc Intervent Radiol 31(2):367–376
Kabayashi S, Nakamura Y, Terada T et al (1993) Postmortem survey of bile duct necrosis and biloma in hepatocellular carcinoma alter transcatheter arterial chemoembolization therapy: relevant to microvascular damages of peribiliary capillary plexus. Am J Gastroenterol 88:1410–1415
Kim HK, Cheng YH, Song BC et al (2001) Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma. J Clin Gastroenterol 32:423–427
Kim HC, Cheng JW, Lee W, Jae HJ, Park JH (2005) Recognizing extrahepatic collateral vessels that supply hepatocellular carcinoma to avid complications of transcatheter arterial chemoembolization. Radiographics 25:S25–S39
Lau WY, Ho S, Leung TW et al (1998) Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres. Int J Radiat Oncol Biol Phys 40:583–592
Leung WT, Lau WY, Ho SK et al (1994) Measuring lung shunting in hepatocellular carcinoma with intrahepatic-arterial technetium-99 m macroaggregated albumin. J Nucl Med 35:70–73
Leung TW, Lau WY, Ho SK et al (1995) Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors. Int J Radiat Oncol Biol Phys 33:919–924
Lewandosky RJ, Sato KT, Atassi B et al (2007) Radioembolization with 90Y microspheres: angiographic and technical considerations. Cadiovasc Intervent Radiol 30:571–592
Liu DM, Salem R, Bui JT et al (2005) Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol 16:911–935
Makuchi M, Sukigara M, Mori T et al (1985) Bile duct necrosis: complication of transcatheter hepatic arterial embolization. Radiology 156:331–334
Mantravadi RV, Spigos DG, Tan WS et al (1982) Intraarterial yttrium 90 in the treatment of hepatic malignancy. Radiology 142:783–786
Nakamura H, Kondoh H (1986) Emphysematous cholecystitis: complications of hepatic arterial embolization. Cardiovasc Intervent Radiol 9:152–153
Northover JMA, Terblanche J (1979) A new look a the arterial supply of the bile duct in man and its surgical implications. Br J Surg 66:379–384
Park WK, Chang JC, Lee HZ, Kim HJ, Choi JH, Gu MJ (2002) A case of resection of biloma with hepatocellular carcinoma after embolization. TaehanKan Hakhoe Chi 8:331–335
Sakamoto I, Iwanaga S, Nagaoki K et al (2003) Intrahepatic biloma formation (bile duct necrosis) after transcatheter arterial chemoembolization. AJR Am J Roentgenol 181:79–87
Salem R, Thurston KG (2006) Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: technical and methodologic considerations. J Vasc Interv Radiol 17:1251–1278
Salem R, Lewandosky RJ, Atassi B et al (2005) Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities. J Vasc Interv Radiol 16:1627–1639
Szyszko T, Al-Nahhas A, Tait P et al (2007) Management and prevention of adverse effects related to treatment of liver tumours with 90Y microspheres. Nucl Med Commun 28:21–24
Wollner IS, Knutsen CA, Ullrich KA et al (1987) Effects of hepatic arterial yttrium-90 microsphere administration alone and combined with regional bromodeoxyuridine infusion in dogs. Cancer Res 47:3285–3290
Yip D, Allen R, Ashton C et al (2004) Radiation-induced ulceration of the stomach secondary to hepatic embolization with radioactive yttrium microspheres in the treatment of metastatic colon cancer. J Gastroenterol Hepatol 19:347–349
Yu JS, Kim KW, Jeong MG et al (2002) Predisposing factors of bile duct injury after transcatheter arterial chemoembolization for hepatic malignancy. Cardiovasc Intervent Radiol 25:270–274
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hoffmann, R., Diaz-Dorronsoro, L., Bilbao, J.I. (2013). Complications and Side Effects. In: Bilbao, J., Reiser, M. (eds) Liver Radioembolization with 90Y Microspheres. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2013_815
Download citation
DOI: https://doi.org/10.1007/174_2013_815
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-36472-3
Online ISBN: 978-3-642-36473-0
eBook Packages: MedicineMedicine (R0)